Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine (Q43283883)
Jump to navigation
Jump to search
scientific article published on 27 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine |
scientific article published on 27 August 2009 |
Statements
1 reference
Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine (English)
1 reference
Takumi Hirata
1 reference
Toshihide Kawai
1 reference
Izumi Takei
1 reference
Mikiya Tokui
1 reference
Osamu Funae
1 reference
Kazunori Miyamoto
1 reference
Mitsuhisa Tabata
1 reference
Takao Saruta
1 reference
Akira Shimada
1 reference
Hiroshi Itoh
1 reference
27 August 2009
1 reference
1 reference
Identifiers
1 reference